Regenerative Medicine and Angiogenesis; Focused on Cardiovascular Disease

Seyed Zachariah Moradi1,2, Faramarz Jalili3, Zohreh Hoseinkhani2

  • 1Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Insights

Regenerative medicine offers new hope for cardiovascular disease (CVD) treatment. This review explores angiogenesis

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Science
  • Angiogenesis Research

Background:

  • Cardiovascular disease (CVD) is a leading cause of global mortality, often linked to blood vessel occlusion.
  • Advanced CVD necessitates interventions to restore blood flow or reduce tissue energy demands.
  • Regenerative medicine, including stem cell therapy, gene therapy, and tissue engineering, presents promising therapeutic avenues for CVD.

Purpose of the Study:

  • To review the beneficial, challenging, and contradictory effects of angiogenesis in cardiovascular disease.
  • To examine angiogenesis in both in vivo and in vitro models relevant to CVD.
  • To inform future research in regenerative medicine for CVD treatment.

Main Methods:

  • Literature review of studies on angiogenesis in cardiovascular disease models.
  • Analysis of in vivo and in vitro experimental data.
  • Synthesis of findings on the role of angiogenesis in CVD.

Main Results:

  • Angiogenesis research in CVD models reveals both positive and negative impacts.
  • Understanding these effects is crucial for developing effective regenerative therapies.
  • Current research highlights the complex role of angiogenesis in CVD.

Conclusions:

  • Angiogenesis holds significant potential as a therapeutic strategy for cardiovascular disease.
  • Further research is needed to overcome challenges and harness angiogenesis effectively.
  • Regenerative medicine approaches, particularly those involving angiogenesis, offer future hope for CVD patients.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K